Mission Helios helps scientists to find their way in the tremendous amount of high quality data produced by the industrialization of cell biology and molecular biology. The challenge for scientists involved in drug target discovery and biomarker discovery is to be able to correctly use experimental and extract meaningful hypotheses.
Helios has developed and validated the new paradigm of modeling the dynamics of cell signaling cascades. With its unique platform, the company builds dynamic models mimicking the behavior of cell signaling cascades. With such models, the selection of reliable therapeutic targets or biomarkers is fastened. Helios has already built various models and characterized therapeutic targets that have been biologically validated.
The company
Helios BioSciences is a spin-off of the CNRS, created in 2002. Since its creation, it has been awarded numerous prizes :
Prize-winner of the Competition of the French Ministry of Research in 2002 for its researches in:
The field of tissue and cell expression "TCE."
The dynamic modeling of pathologies of the Central Nervous System, notably epilepsy.
Prize-winner of the Springboards of the Creation in Human Health of the foundation Aventis-Institut of France in 2003.
